Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I guess the problem with SNG was pinning all its hope on Covid only and the trials/results were all very slow. With vaccination coming through and more than 2 years, there was little value in any such medicine/therapy but still if had succeeded the trials, there would have been some hope.
That has not changed at all but there is a risk always. Pharma companies move to phase 3 based on the data and the results but still fail just like SNG. My question was is Tox result single point of failure for SAR or is that just one of the many outcomes related with multiple products.
Hi Thot and other experts - I have a query if you could answer please. I am heavily invested here and want SAR to multiply from here. Looking at SNG yesterday, I am a bit worried on the prospects of every pharma share now and hence my question. How are we covered in SAR in case the results does not turn out to be as expected. Is SAR solely reliant on the tox results now or is that just one of the many milestones ?